Efficacy and tolerability of trimetazidine in stable angina: A meta-analysis of randomized, double-blind, controlled trials

Coronary Artery Disease

Volumn 14, Issue 2, 2003, Pages 171-179

  Marzilli, Mario ^a   Klein, Werner W ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Double blind trials; Meta analysis; Randomized; Stable angina; Trimetazidine

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DILTIAZEM; ISOSORBIDE DINITRATE; METOPROLOL; NIFEDIPINE; NITRATE; PLACEBO; PRENYLAMINE; PROPRANOLOL; TRIMETAZIDINE;

ADULT; AGED; ANOREXIA; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; EMBASE; EPIGASTRIC BURNING; EPIGASTRIC PAIN; EXERCISE; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDLINE; META ANALYSIS; MUSCLE CRAMP; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT DEPRESSION; STABLE ANGINA PECTORIS; TREATMENT OUTCOME;

AGED; ANGINA PECTORIS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; NITROGLYCERIN; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TRIMETAZIDINE; VASODILATOR AGENTS;

EID: 0037732581     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200304000-00010     Document Type: Article

References (34)

1. Gibbons RJ, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol 1999; 33:2092-2197.
2. Task Force of the European Society of Cardiology. Management of stable angina pectoris: recommendations of the Task Force of the European Society of Cardiology. Eur Heart J 1997; 18:394-413.
3. Kantor P, Lucien A, Kozak R, Lopaschuk G. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ Res 2000; 86:580-588.
4. El Banani H, Bernard M, Baetz D, Cabanes E, Cizzone P, Lucien A, Feuvray D. Changes in intracellular sodium and pH during ischemia-reperfusion are attenuated by trimetazidine. Comparison between low- and zero-flow ischemia. Cardiovasc Res 2000; 47:688-696.
5. Sentex E, Sergiel JP, Lucien A, Grynberg A. Trimetazidine increases phospholipid turnover in ventricular myocyte. Mol Cell Biochem 1997; 175:153-162.
6. Jackson G. Stable angina: maximal medical therapy is not the same as optimal medical therapy. Int J Clin Pract 2000; 54:351.
7. Jackson G. Combination therapy in angina: a review of combined haemodynamic treatment and the role for combined haemodynamic and cardiac metabolic agents. Int J Clin Pract 2001; 55:256-261.
8. Dargie HJ, Ford I, Fox M, on behalf of the total ischemic burden European Trial (TIBET) group. Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group. Eur Heart J 1996; 17:104-112.
9. Savanitto S, Ardissino D, Egstrup K et al., on behalf of the International Multicenter AnGina Exercise (IMAGE) study group. Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. J Am Coll Cardiol 1996; 27:311-316.
10. Ferguson JD, Ormerod O, Lenox-Smith AJ. Bisoprolol alone and in combination with amlodipine or nifedipine in the treatment of chronic stable angina. Int J Clin Pract 2000; 54:360-363.
11. Klein W, Jackson G, Tavazzi L. Efficacy of monotherapy versus combined antianginal drugs in the treatment of chronic stable angina L. Coron Artery Dis 2002; 13:427-436.
12. McClellan KJ, Plosker GL. Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions. Drugs 1999; 58:143-157.
13. Hedges LV, Olkin J. Statistical methods for meta-analysis. Elsevier: Academic Press Inc.; 1985.
14. Ayudhya RK, Yipintsoi T, Jintapakorn W, Suntiparpluacha C, Yipintsoi S. Trimetazidine and stable angina a double-blind trial. J Med Assoc Thai 1990; 73:162-167.
15. Sellier P, Audouin P, Payen B, Duong TC, Ourbak P. Ergometric effects of a single administration of trimetazidine. Presse Med 1986; 15:1771-1774.
16. Lu C, Dabrowski P, Fragasso G, Chierchia SL. Effects of trimetazidine on ischemic left ventricular dysfunction in patients with coronary artery disease. Am J Cardiol 1998 Oct 1; 82(7):898-901.
17. Nalbantgil S, Altintig A, Yilmaz H, Nalbantgil I, Onder R. The effect of trimetazidine in the treatment of microvascular angina. Int J Angiol 1999; 8:40-43.
18. Szwed H, Sadowski Z, Elikowski W, KoronKiewizc A et al. Trimpol II: combination treatment of stable effort angina using trimetazidine and metoprolol: results of a randomised, double blind, multicentre study. Eur Heart J 2001; 22:2267-2274.
19. Michaelides AP, Spiropoulos K, Dimopoulos K, Athanasiades D, Toutouzas P. Antianginal efficacy of the combination of trimetazidine-propranolol compared with isosorbide dinitrate-propranolol in patients with stable angina. Clin Drug Inv 1997; 13:8-14.
20. Levy S. Combination therapy of trimetazidine with diltiazem in patients with coronary artery disease. Group of South of France Investigators. Am J Cardiol 1995; 76:12B-16B.
21. Manchanda SC, Krishnaswami S. Combination treatment with trimetazidine and diltiazem in stable angina pectoris. Heart 1997; 78:353-357.
22. Dalla-Volta S, Maraglino G, Della-Valentina P, Viena P, Desideri A. Comparison of trimetazidine with nifedipine in effort angina: a double-blind, crossover study. Cardiovasc Drugs Ther 1990; 4 (suppl 4):853-859.
23. Grosgogeat Y, Bourdarias JP. Controlled trial of the antianginal activity of trimetazidine: double blind cross-over trial versus reference drug (prenylamine). Int J Clin Pract (Hong-Kong) 1987; 3:31-36.
24. Aksoyek S, Kabukçu M, Övünç K, Kabakci G, Aytemir K, Oto A. Clinical efficacy of trimetazidine in stable angina pectoris: A double blind placebo controlled study. Turk Kardiyol Dern Ars 1996; 24:289-292.
25. Detry JM, Sellier P, Pennaforte S, Cokkinos D, Dargie H, Mathes P. Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group. Br J Clin Pharmacol 1994; 37:279-288.
26. Passeron J. Effectiveness of trimetazidine in stable effort angina due to chronic coronary insufficiency. A double-blind versus placebo study. Presse Med 1986; 15:1775-1778.
27. Prasad R, Singh HK. The efficacy of trimetazidine in stable effort angina. A double-blind, placebo controlled study. Ind Med J 1989; 83:54-58.
28. Gallet M. Clinical effectiveness of trimetazidine in stable effort angina. A double-blind versus placebo controlled study. Presse Med 1986; 15:1779-1782.
29. Deroux A, Brochier M, Demange J, Ducloux G, Monpere C, Warin JF. Therapeutic value of a combination of trimetazidine with a calcium inhibitor in the treatment of chronic coronary insufficiency. Presse Med 1986; 15:1783-1787.
30. Picano E, on behalf of the PISA (Persantin In Stable Angina) study group. Dipyridamole in chronic stable angina pectoris; a randomized, double blind, placebo-controlled, parallel group study. J Am Coll Cardiol 2000; 36:1967-1971.
31. Stason WB, Schmid CH, Niedzwiecki D, Whiting GW, Caubet JF, Cory D, et al. Safety of nifedipine in angina pectoris: a meta-analysis. Hypertension 1999; 33:24-31.
32. Heidenreich PA, McDonald KM, Hastie T, Fadel B, Hagan V, Lee BK, et al. Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina. JAMA 1999; 281:1927-1936.
33. Packer M. Drug therapy. Combined beta-adrenergic and calcium-entry blockade in angina pectoris. N Engl J Med 1989; 320:709-718.
34. Sellier P, Harpey C, Corona P, Audouin P, Ourbak P. Acute effects of trimetazidine on ergometric parameters in effort angina. Cardiovasc Drugs Ther 1990; 4 (suppl 4):820-821.